Table. 1.

Structural parameters of trabecular and cortical bone calculated from micro-CT images in mice

Days Day 0 Day 12 Day 19




Group Pre-treatment Control FPM LPS Control FPM LPS
Trabecular bone
BMD (g/cm3) 0.19 ± 0.03 0.19 ± 0.04 0.16 ± 0.04 0.10 ± 0.02** 0.16 ± 0.04 0.14 ± 0.03** 0.09 ± 0.02**
BV/TV (%) 42.28 ± 10.35 39.02 ± 12.93 32.11 ± 12.10 12.34 ± 4.06** 31.27 ± 11.10 25.59 ± 10.19** 13.79 ± 3.92**
Tb.Th (mm) 0.13 ± 0.02 0.13 ± 0.02 0.11 ± 0.02 0.10 ± 0.01 0.12 ± 0.02 0.11 ± 0.02 0.10 ± 0.01
BS/BV (1/mm) 29.94 ± 5.11 30.93 ± 6.08 35.62 ± 8.39 44.18 ± 4.25** 34.33 ± 6.97 38.62 ± 8.99* 40.98 ± 3.59*
Tb.Sp (mm) 0.20 ± 0.05 0.21 ± 0.06 0.23 ± 0.05 0.42 ± 0.11** 0.26 ± 0.06 0.34 ± 0.08** 0.51 ± 0.13**
Tb.N (1/mm) 3.30 ± 0.39 3.00 ± 0.69 2.71 ± 0.71 1.26 ± 0.41** 2.52 ± 0.63 2.25 ± 0.68** 1.33 ± 0.30**
Cortical bone
BMD (g/cm3) 0.67 ± 0.02 0.68 ± 0.04 0.67 ± 0.03 0.66 ± 0.03 0.65 ± 0.02 0.64 ± 0.03 0.65 ± 0.05
Cs.Th (mm) 0.18 ± 0.02 0.19 ± 0.02 0.18 ± 0.03 0.16 ± 0.02 0.18 ± 0.02 0.17 ± 0.03 0.15 ± 0.03
Ct.BV (mm3) 0.99 ± 0.09 1.10 ± 0.11 1.00 ± 0.14 0.88 ± 0.05 1.03 ± 0.13 0.91 ± 0.14 0.80 ± 0.12
MMI (mm4) 0.78 ± 0.11 0.92 ± 0.12 0.82 ± 0.13 0.71 ± 0.07 0.84 ± 0.15 0.73 ± 0.13 0.64 ± 0.06

Values are presented as mean ± standard deviation. Pre-treatment group (Day 0) vs. control group, FPM-treated group, LPS-treated group. *p < 0.05, **p < 0.01, Kruskal–Wallis test. CT, computed tomography; FPM, fine particulate matter; LPS, lipopolysaccharide; BMD, bone mineral density; BV/TV, bone volume/total volume; Tb.Th, trabecular thickness; BS/BV, bone surface to bone volume ratio; Th.Sp, trabecular separation; Tb.N, trabecular number; Cs.Th, cross-sectional thickness; Ct.BV, cortical bone volume; MMI, mean polar moment of inertia.

Korean J Physiol Pharmacol 2025;29:9-19 https://doi.org/10.4196/kjpp.24.115
© Korean J Physiol Pharmacol